OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-52687MFV610
Recombinant Monoclonal Antibody
![OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE]](https://resources.bio-techne.com/images/products/nbp2-52687mfv610_rabbit-ox40-ligand-tnfsf4-mab-r4930-oxelumab-mfv610-se-672023859832.png "OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE] [NBP2-52687MFV610] -")
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Block/Neutralize, Flow Cytometry, CyTOF-ready
Label
mFluor Violet 610 SE (Excitation = 421 nm, Emission = 613 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Kappa Clone # R4930 (Oxelumab)
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
Specificity
Binds to human OX40L.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Description
This conjugate is made on demand and is not held in inventory. Each order represents a unique lot. All conjugates are generated using validated conjugation protocols and meet strict degree of labeling (F/P) specifications; additional information is available upon request. The antibody concentration is provided on the individual product label.
For specialized conjugation needs, like large quantities, specific concentrations, and defined F/P ratios, bulk and custom antibody conjugation services are available.
For specialized conjugation needs, like large quantities, specific concentrations, and defined F/P ratios, bulk and custom antibody conjugation services are available.
Scientific Data Images for OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE]
OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE] [NBP2-52687MFV610] -
OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE] [NBP2-52687MFV610] - Vial of mFluor Violet 610 conjugated antibody. mFluor Violet 610 is optimally excited at 421 nm by the Violet laser (405 nm) and has an emission maximum of 613 nm.Applications for OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE]
Application
Recommended Usage
Block/Neutralize
Optimal dilutions of this antibody should be experimentally determined.
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Recommended applications are based on validated applications from the unconjugated base product NBP2-52687. This conjugated antibody is not kept in inventory and is made to order using validated conjugation protocols.
Spectra Viewer
Plan Your Experiments
Use our spectra viewer to interactively plan your experiments, assessing multiplexing options. View the excitation and emission spectra for our fluorescent dye range and other commonly used dyes.
Spectra Viewer
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: OX40 Ligand/TNFSF4
Alternate Names
CD252, gp34, TNFSF4
Gene Symbol
TNFSF4
Additional OX40 Ligand/TNFSF4 Products
Product Documents for OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE]
Product Specific Notices for OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [mFluor Violet 610 SE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...